Literature DB >> 2785144

A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity.

T Volgmann1, A Klein-Struckmeier, H Mohr.   

Abstract

A fluorescence assay for the quantitation of tumor cell lysis by activated and non-activated killer (LAK) cells is described. The target cells are labelled with a europium chelate (Eu-diethylenetriaminopentaacetate) and after cytolysis caused by the LAK cells the Eu3+ complex is released into the culture supernatant. The addition of beta-naphthoyltrifluoroacetone to culture supernatant aliquots leads to the formation of a highly fluorescent chelate which can be measured with a time-resolved fluorometer. The influence of various assay parameters has been evaluated including incubation time, effector-to-target cell ratio, the target cell line and different concentrations of interleukin-2 during cell culture. The optimized time-resolved fluorometric assay was found to be as simple and sensitive as the commonly used cytotoxicity assay in which the release of 51Cr from the labelled target cells is measured. In addition the assay is much faster and safer since the label is not radioactive.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785144     DOI: 10.1016/0022-1759(89)90379-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  13 in total

1.  Generation of MHC class I-restricted cytotoxic T cell lines and clones against colonic epithelial cells from ulcerative colitis.

Authors:  Y Yonamine; M Watanabe; F Kinjo; T Hibi
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.317

2.  A GFP-transfected HFWT cell line, GHINK-1, as a novel target for non-RI activated natural killer cytotoxicity assay.

Authors:  Hideki Harada; Kaoru Saijo; Isamu Ishiwata; Tadao Ohno
Journal:  Hum Cell       Date:  2004-03       Impact factor: 4.174

3.  Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis.

Authors:  U Reinhold; S Kukel; B Goeden; U Neumann; H W Kreysel
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

4.  Determination of human γδ T cell-mediated cytotoxicity using a non-radioactive assay system.

Authors:  Mohammed S O Tagod; Satoshi Mizuta; Yuki Sakai; Masashi Iwasaki; Kengo Shiraishi; Hiroaki Senju; Hiroshi Mukae; Craig T Morita; Yoshimasa Tanaka
Journal:  J Immunol Methods       Date:  2019-01-14       Impact factor: 2.303

5.  Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma.

Authors:  P von Zons; P Crowley-Nowick; D Friberg; M Bell; U Koldovsky; T L Whiteside
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

6.  Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells.

Authors:  Smita K Nair; Michael Morse; David Boczkowski; R Ian Cumming; Ljiljana Vasovic; Eli Gilboa; H Kim Lyerly
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

7.  Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.

Authors:  Smita K Nair; Gabriel De Leon; David Boczkowski; Robert Schmittling; Weihua Xie; Janet Staats; Rebecca Liu; Laura A Johnson; Kent Weinhold; Gary E Archer; John H Sampson; Duane A Mitchell
Journal:  Clin Cancer Res       Date:  2014-03-21       Impact factor: 12.531

8.  OVA-specific CD8+ T cells do not express granzyme B during anterior chamber associated immune deviation.

Authors:  Yalin Ren; Peizeng Yang; Bing Li; Yang Gao; Hongyan Zhou; Xiangkun Huang; Lianxiang Zhu; Aize Kijlstra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-15       Impact factor: 3.117

9.  Live Cell Labeling with Terpyridine Derivative Proligands to Measure Cytotoxicity Mediated by Immune Cells.

Authors:  Yuki Sakai; Satoshi Mizuta; Asuka Kumagai; Mohammed S O Tagod; Hiroaki Senju; Tatsufumi Nakamura; Craig T Morita; Yoshimasa Tanaka
Journal:  ChemMedChem       Date:  2017-12-04       Impact factor: 3.466

10.  Modulation of natural and interleukin-2-induced tumour-cytolytic activities by the members of a protein family related to beta-thromboglobulin.

Authors:  A Klein-Struckmeier; J Knüver-Hopf; H Mohr
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.